Cognitive Control Training in Online Problem Gambling (TRAIN-ONLINE)

February 14, 2024 updated by: Assistance Publique - Hôpitaux de Paris

Cognitive Control Training in Online Problem Gambling: an Online Randomized Controlled Trial Among Non-treatment Seeking Problem Gamblers

An online single blinding, randomized, comparative therapeutic web-based, controlled trial. The main objective of the study is to assess the clinical efficacy of an online computerized cognitive training program targeted on cognitive control, namely on inhibition, measured with the PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks, as compared to a control program with a similar setting.

Study Overview

Status

Active, not recruiting

Detailed Description

Cognitive training is currently used in brain damaged patients and in some psychiatric conditions, like schizophrenia or depression. Very few cognitive training programs have been published and tested in addictive disorders.

Training online is currently proposed in standard care, and is listed as recommended activities in daily hospitalization in addiction specialized out-settings in France.

The purpose of this research is to test the efficacy of an online intervention in gambling addiction through cognitive training targeting cognitive control inhibition.

The experimental Intervention (Cognitive Training) is a computerized cognitive training targeting inhibitory control of motor response (Scientific Brain Training®).The tasks included in the program have been selected and modified to target inhibition.

Control intervention is a sensorial program with a similar format targeting visual acuity. This is not a cognitive program, and can be considered as neutral in the addiction field.

An optional guidance by phone performed by a trained neuropsychologist is proposed to the included subjects in both groups, up to15 minutes twice a week.

Study design: A therapeutic web-based, comparative, randomized controlled trial, 2 arms, single blinding, with 52 weeks follow-up:

  • a 14 weeks patient follow up (6 weeks for efficacy assessment and maintenance at 14 weeks).
  • 52 weeks gambling account based data extracted from the ARJEL database in last 4 weeks before baseline, week 6, week 14 and week 52.

Population of study participants : Problem gamblers who will contact the responsible of the study.

Schedule for the study :

  • Duration of inclusion period: 8 months
  • Duration of patient participation: 52 weeks (12 months) including 14 weeks of active gambler participation and up to 52 weeks for the collection of gambler data from the ARJEL database.
  • Total research duration: 20 months Main objective : To assess the clinical efficacy of an online computerized cognitive training program targeted on cognitive control, namely on inhibition, measured with the PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks.

Secondary objectives of the study are:

  • to assess the efficacy on the evolution of the gambling behaviour assessed by the account player based gambling data, at 6, 14and 52 weeks.
  • to assess the efficacy on the evolution of the self-reported gambling practice, and of quality of life at 0, 6 and 14 weeks.
  • to assess the efficacy on the evolution of inhibition performance at the neuropsychological level at 0, 6 and 14, weeks.
  • We will also assess the acceptability of this program and the preferred level of guidance of the non-treatment seeking problem gamblers as factor of response.

Statistical analysis:The change in PGSI-recent total score over 6 weeks will be compared with the student's t-test. If the test application conditions are not met, a Wilcoxon test will be applied.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Villejuif, France, 94800
        • Paul Brousse Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria

  1. Over 18 years old gamblers
  2. Willing to share his/her first name, last name, exact birthdate, and exact place of birth (city + department). These informations are needed to extract ARJEL player account based gambling data, to avoid any doubloon or homonym.
  3. PGSI-recent ≥ 5.
  4. Recipient or beneficiary of the French social security system and resident in France.

Non-inclusion criteria

1. Gamblers cannot speak or understand French

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Training
Online Cognitive training on the Scientific Brain Training® (SBT®) platform with optional guidance by phone
Cognitive web-based training : 2 up to 30 minutes sessions a week during 6 weeks. Optional debriefing by a neuropsychologist up to 15 minutes twice a week
Other Names:
  • Cognitive training with optional guidance by phone
Sham Comparator: Online sensorial program
Online sensorial program on the Scientific Brain Training® (SBT®) platform with optional guidance by phone
Sensorial web-based training : 2 up to 30 minutes sessions a week during 6 weeks. Optional debriefing by a neuropsychologist up to 15 minutes twice a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change over 6 weeks in Problem gambling severity index (PGSI)-recent total score, collected by internet
Time Frame: Change from baseline at 6 weeks
PGSI-recent, a modified version of Problem Gambling Severity Index (PGSI) with a 30 days recall period in patients with problem gambling, at 6 weeks
Change from baseline at 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Problem gambling severity index - recent (PGSI)
Time Frame: Between baseline (T0) , and 14 weeks (T2)
Between baseline (T0) , and 14 weeks (T2)
Short form of Urgency, Premeditation, Perseverance, Sensation seeking, and Positive urgency (UPPS-P) Impulsive behavior scale
Time Frame: Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Impulsivity scale
Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Time Line Follow Back (TLFB) -gambling
Time Frame: Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Money and time spent gambling including offline gambling
Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
EuroQol five dimensions questionnaire (EQ-5D)
Time Frame: Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Health related quality of life self-questionnaire
Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Gambling Quality of Life Scale (GQoLS)
Time Frame: Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Health related quality of life self-questionnaire specific to gambling disorder
Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Neuropsychological assessment: Stop Signal Task (SST)
Time Frame: Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Cognitive task assessing inhibition
Between baseline (T0) , 6 weeks (T1) and 14 weeks (T2)
Total Deposit
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Total Deposit assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Total stake by game
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Total stake by game assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Compulsivity
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Compulsivity (as defined by three consecutive deposits in a 12-hour period of time) assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Number of deposit in the hour following a stake
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Number of deposit in the hour following a stake assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Total loss by game
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Total loss by game assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Number of sessions (all games)
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Number of sessions (all games) in a clinical meaning assessed by the account player based gambling data (ARJEL database) Session is defined as gambling behaviour in itself; we'll consider the beginning of a session when a gambling action occurs after no gambling action since at least 30 minutes, and the end of the gambling session a gambling action followed by no gambling action during 30 minutes.
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Session duration (poker only)
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Session duration (poker only) assessed by the account player based gambling data (ARJEL database)
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Gambling time slot
Time Frame: In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)

Gambling time slot assessed by the account player based gambling data (ARJEL database).

The time slots are divided as follows:

  1. 0:00 to 3 :59
  2. 4:00 to 7:59
  3. 8:00 to 11:59
  4. 12:00 to 15:59
  5. 16:00 to 19:59
  6. 20:00 to 23:59
In last 4 weeks before baseline (T0) , 6 weeks (T1), 14 weeks (T2) and 52 weeks (T3)
Acceptability of the online program assessed by the number of training session
Time Frame: At 6 week (T1)
At 6 week (T1)
Acceptability of the online program assessed by the length of training session
Time Frame: At 6 week (T1)
At 6 week (T1)
Level of guidance assessed by the number of phone session
Time Frame: At 6 week (T1)
Number of debriefing by phone sessions
At 6 week (T1)
Level of guidance assessed by the length of phone session
Time Frame: At 6 week (T1)
Length of debriefing by phone sessions
At 6 week (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amandine LUQUIENS, MD, PhD, HDR, Assistance Publique Hoptiaux de Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2019

Primary Completion (Actual)

June 6, 2023

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

August 27, 2018

First Submitted That Met QC Criteria

September 14, 2018

First Posted (Actual)

September 17, 2018

Study Record Updates

Last Update Posted (Estimated)

February 15, 2024

Last Update Submitted That Met QC Criteria

February 14, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P170601
  • 2017-A01666-47 (Other Identifier: IDRCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pathological Gambling

Clinical Trials on Experimental Group

3
Subscribe